01 Gangwal Healthcare (2)
02 Actylis (4)
03 BASF (6)
04 Curia (1)
05 Microlex e.U (3)
01 Capsule (2)
02 Emulsion (1)
03 Injectable / Parenteral (2)
04 Ophthalmic Solution (1)
05 Softgel Capsule (1)
06 Solution (1)
07 Tablet (7)
08 Topical Film (1)
01 Austria (3)
02 Germany (6)
03 India (2)
04 U.S.A (5)
Applications:
Ingredient(s): Tyloxapol
Category: Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers
Technical Specifications: NA
Applications:
Tyloxapol excipient is used as an solubilizing agent in the ophthalmic products.
Ingredient(s): Tyloxapol
Dosage Form: Ophthalmic Solution
Category: Solubilizers
Technical Specifications: US DMF Available
Applications:
A&C’s Benzalkonium Chloride 17% is a preservative which meets the NF monograph.
Ingredient(s): Benzalkonium chloride excipient
Dosage Form: Injectable / Parenteral, Tablet
Category: Solubilizers
Technical Specifications: 17% USP NF
Applications:
Ingredient(s): Benzalkonium chloride excipient
Dosage Form: Injectable / Parenteral, Tablet
Category: Solubilizers
Technical Specifications: 50% NF
Applications:
It provides solubility and viscosity stability on medium viscosity.
Ingredient(s): Carboxymethyl cellulose sodium
Dosage Form: Tablet
Category: Solubilizers, Thickeners and Stabilizers
Technical Specifications: Medium Viscosity
Applications:
It provides smooth solutions, based on uniform substitution with low viscosity.
Ingredient(s): Carboxymethyl cellulose sodium
Dosage Form: Tablet
Category: Solubilizers, Thickeners and Stabilizers
Technical Specifications: Low Viscosity
Applications:
It provides solubility and viscosity stability on strong high viscosity.
Ingredient(s): Carboxymethyl cellulose sodium
Dosage Form: Tablet
Category: Solubilizers, Thickeners and Stabilizers
Technical Specifications: Strong High Viscosity
Applications:
Ingredient(s): Propylene Glycol
Dosage Form: Capsule, Emulsion, Softgel Capsule, Solution, Tablet, Topical Film
Category: Film Formers & Plasticizers, Solubilizers, Topical
Technical Specifications: Not Available